TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group
Forlagets udgivne version, 618 KB, PDF-dokument
| Originalsprog | Engelsk |
|---|---|
| Artikelnummer | 360 |
| Tidsskrift | B M C Cancer |
| Vol/bind | 14 |
| Antal sider | 14 |
| ISSN | 1471-2407 |
| DOI | |
| Status | Udgivet - 2014 |
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
Ingen data tilgængelig
ID: 125791294